Serialization continues to evolve as an essential aspect of pharmaceutical manufacturing, ensuring product traceability and enhancing safety standards. This session will explore key global regulatory developments, from the European Union’s Falsified Medicines Directive (FMD) to new initiatives launched by Brazil and Indonesia. Attendees will gain insights into the regulatory shifts occurring worldwide and how these are shaping the future of serialization. The session will also focus on technical considerations, particularly the migration from 1D to 2D barcodes, and how digital serialization can provide long-term solutions for the industry. In this session, you will learn more about:

• The global regulatory landscape and key developments in serialization, including FMD, and new initiatives in Brazil and Indonesia.
• The transition from 1D to 2D barcodes: challenges, technical considerations, and best practices to ensure a smooth migration.
• How digital serialization is shaping the future of the industry and the opportunities for pharmaceutical companies to stay ahead of evolving regulations.